In this presentation, from the 2021 Spatial Biology Europe Congress, Gavin Gordon, Ph.D., Vice President, Clinical Market Development from Akoya Biosciences describes evolving biomarker strategies in immuno-oncology and how multiplexed immunofluorescence has been associated with improved predictive performance. Dr Sebastian Marwitz, ARCN Principal Investigator, Pathology from Research Center Borstel – Leibniz Lung Center, describes how multiplexed IHC has been used for the spatial profiling in lung disease in hypotheses-driven analyses at a cohort level using FFPE patient samples.